James B. Gerstner
Impact in
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Screening and Detection
-
- Genetic factors in colorectal cancer
Papers in
- Co-authors
- James E. KrookHarry S. WieandCarl G. KardinalRalph LevittJ A MailliardG McCormackJohn A. LaurieC G Moertel
- Journals
- Journal of Clinical Oncology (10 papers)Cancer (3 papers)American Journal of Hematology (1 paper)Cancer Investigation (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)
- Partner nations
- United StatesIndiaCanada
In The Last Decade
James B. Gerstner
29 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 1.6k
- Pathology and Forensic Medicine 421
- Pulmonary and Respiratory Medicine 544
- Hepatology 124
- Cancer Research 138
Countries citing papers authored by James B. Gerstner
This map shows the geographic impact of James B. Gerstner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James B. Gerstner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James B. Gerstner more than expected).
Fields of papers citing papers by James B. Gerstner
This network shows the impact of papers produced by James B. Gerstner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James B. Gerstner. The network helps show where James B. Gerstner may publish in the future.
Co-authors
The 25 scholars most cited alongside James B. Gerstner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 7 | |
| 2 | 1999 | 3 | |
| 3 | 1999 | 18 | |
| 4 | 1999 | 48 | |
| 5 | 1997 | 52 | |
| 6 | 1997 | 51 | |
| 7 | 1996 | 48 | |
| 8 | 1995 | 33 | |
| 9 | 1995 | 53 | |
| 10 | 1994 | 95 | |
| 11 | 1994 | 69 | |
| 12 | 1994 | 248 | |
| 13 | 1993 | 36 | |
| 14 | 1991 | 298 | |
| 15 | 1990 | 11 | |
| 16 | 1990 | 158 | |
| 17 | 1989 | 14 | |
| 18 | 1989 | 8 | |
| 19 | Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. Hit paper breakdown → | 1989 | 526 |
| 20 | 1989 | 4 |
About James B. Gerstner
James B. Gerstner is a scholar working on Oncology, Genetics, Hematology, Reproductive Medicine and Pharmacology, having authored 29 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (7 papers), Colorectal Cancer Treatments and Studies (6 papers), Cancer therapeutics and mechanisms (6 papers), Neuroendocrine Tumor Research Advances (5 papers), Cancer Treatment and Pharmacology (5 papers), Genetic factors in colorectal cancer (3 papers), Neutropenia and Cancer Infections (3 papers) and Gastric Cancer Management and Outcomes (3 papers). The work is most often cited by research in Oncology (1.6k citations), Pathology and Forensic Medicine (421 citations), Pulmonary and Respiratory Medicine (544 citations), Hepatology (124 citations) and Cancer Research (138 citations). James B. Gerstner has collaborated with scholars based in United States, India and Canada. Frequent co-authors include James E. Krook, Harry S. Wieand, Carl G. Kardinal, Ralph Levitt, J A Mailliard, G McCormack, John A. Laurie, C G Moertel, Thomas R. Fleming and Joseph Rubin. Their work appears in journals such as Journal of Clinical Oncology, Cancer, American Journal of Hematology, Cancer Investigation and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.